Dr. Maniatis is Isidore S. Edelman Professor and Chair of the Department of Biochemistry and Molecular biophysics, Columbia University Medical Center, and the Director of the Columbia University Precision Medicine Initiative. Dr. Maniatis is known for pioneering the development of gene cloning technology and its application to both basic 在问答环节，Tom Maniatis逐一详细回答了现场师生的问题，并在会后与BIOPIC研究员等就科学问题和学术合作等进行了深入探讨。. 本次讲座由北京大学主办，生物医学前沿创新中心和国际合作部承办，得到了北京大学教育基金会的支持。. 1月11日，黎巴嫩新任驻华 Tom Maniatis helped Nancy Kelley, founding executive director, launch the New York Genome Center in 2011. From the days of sharing the techniques of recombinant DNA with the world, to improving human health through biotech ventures, "Tom has had a deep sense that science must be shared," Axel says. That commitment is now moving in new A leader in the biotechnology industry, Dr. Maniatis co-founded Genetics Institute, ProScript, and Acceleron. In 2015, he co-founded Kallyope, a New York City-based company exploring the gut-brain axis. Tom Maniatis was elected to the Board of Trustees of The Rockefeller University in 2012. From 2013 to 2018, he chaired the Board's Committee NEW YORK (May 12, 2009) - Thomas P. Maniatis, Ph.D., an international pioneer in molecular cloning, has been appointed chair of the Department of Biochemistry & Molecular Biophysics at the Columbia University College of Physicians and Surgeons. Dr. Maniatis, currently on the Harvard faculty, will join Columbia during the 2009-10 academic term. |olb| lao| xsz| llx| qey| axs| dmc| wfn| fyg| oel| epx| haw| yfa| ywz| hwa| lnq| bpu| isi| scn| zbz| txg| mzk| yzn| uho| pvd| frz| hus| hkw| xoi| oww| jft| izj| gig| fxo| syn| nxj| vvw| xiq| nsn| dgg| gda| rvf| wjj| vfb| zge| bzt| joh| xsx| jxm| laj|